Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132417) titled 'Proteomics-Driven Predictive Modeling and Validation of Non-Response to Neoadjuvant Chemoimmunotherapy in Locally Advanced Gastric Cancer: A Multicenter Real-World Study' on Sept. 14.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The First Medical Center of Chinese PLA General Hospital
Condition:
Locally advanced gastric cancer
Intervention:
Gold Standard:Pathological examination
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-21
Target Sample Size: Target condition:297;Difficult condition:0
Countries of Recruitment:
China...